ZH - NS MNTS and AGRX among pre market gainers

Kezar Life Sciences (KZR) +93% after mid-stage data for lupus nephritis candidate. Agile Therapeutics (AGRX) +46%. Evofem Biosciences (EVFM) +33% collaboration for birth control method. InflaRx (IFRX) +17% on vilobelimab getting FDA orphan drug status for skin disorder. Ceragon Networks (CRNT) +16% as Aviat offers to buy rest in $235M deal. Trip.com Group  (TCOM) +16% on strong travel recovery led by staycation travel and local hotel bookings. Sutro Biopharma (STRO) +14% after announcing worldwide strategic collaboration with Astellas Pharma. Wejo Group (WEJO) +14% connected vehicle data across Europe to enable end-to-end insurance offerings. Melco Resorts & Entertainment (MLCO) +12% stocks soar after China eases COVID quarantine rules. Huazhu Group (HTHT) +10%. Apyx Medical (APYX) +9% on FDA clearance for wrinkle resuction procedures. BioLineRx (BLRX) +8% collaboration agreement with GenFleet Therapeutics to further develop Motixafortide in Pancreatic Ductal Adenocarcinoma. Las Vegas Sands  (LVS) +8% after China eases COVID quarantine rules. The9 Limited (NCTY) +8%. Wynn Resorts (WYNN) +8% after China eases COVID quarantine rules. MSP Recovery (MSPR)

For further details see:

NS, MNTS and AGRX among pre market gainers